Mutant Brown-Norway-Katholiek (muBN-Ka) rats are capable of producing kininogens in the liver, but cannot release them into the bloodstream, because of the point mutation of Ala163 to Thr in the ...

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Sodium Channel Blockers - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Sodium Channel Blockers - Pipeline Insight, ...

PHILADELPHIA -- An oral, non-addictive sodium channel blocker safely relieved moderate-to-severe acute pain following surgery, according to phase III data that could support regulatory approval.

Several studies examining the use of sodium-channel blockers in patients with multiple sclerosis are currently underway. Questions about the long-term effects of these agents in neuroinflammatory ...

South Korea’s SK Biopharmaceuticals Co. Ltd. and Shanghai-based Ignis Therapeutic Co. Ltd. signed a ₩804 billion (US$58 million) licensing deal on April 18, granting the latter global rights to a ...

May 19, 2009 (San Diego, California) — A novel aerosol therapy in development for cystic fibrosis (CF) patients that increases airway surface liquid while reducing the buildup of mucous has shown ...

BACKGROUND: Atrial fibrillation and other cardiac arrhythmias pose a major public health burden, but prevention remains ...

ATS 2009, SAN DIEGO—Cystic fibrosis patients may benefit from a new therapy that increases airway hydration, preventing the buildup of mucous, which is a key factor in the disease, according to ...

Dr. Naccarelli answers the question: 'What Is Flecainide, How Does It Work?' — -- Question: I have been placed on an antiarrhythmic drug called flecainide for my heart rhythm problem. How does it ...

(MENAFN- GlobeNewsWire - Nasdaq) The sodium channel blockers market presents opportunities in treating conditions like arrhythmias, epilepsy, and neuropathic pain due to their action on sodium ...